TipRanks
Omeros Corp (DE:3O8)
FRANKFURT:3O8
Germany Market

Omeros (3O8) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

3O8 Analyst Ratings

Moderate Buy
3Ratings
Moderate Buy
2 Buy
1 Hold
0 Sell
Based on 3 analysts giving stock ratings to
Omeros
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

3O8 Stock 12 Month Forecast

Average Price Target

€24.54
▲(52.43% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Omeros in the last 3 months. The average price target is €24.54 with a high forecast of €29.45 and a low forecast of €19.63. The average price target represents a 52.43% change from the last price of €16.10.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"€2","9":"€9","16":"€16","23":"€23","30":"€30"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":29.44853604,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€29.45</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24.5404467,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€24.54</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":19.63235736,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€19.63</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,9,16,23,30],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.85,17.81911815692308,18.788236313846156,19.757354470769233,20.72647262769231,21.695590784615387,22.664708941538464,23.633827098461538,24.60294525538462,25.572063412307692,26.541181569230773,27.510299726153846,28.479417883076923,{"y":29.44853604,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.85,17.441572823076925,18.033145646153848,18.62471846923077,19.216291292307695,19.807864115384618,20.39943693846154,20.991009761538464,21.582582584615388,22.17415540769231,22.765728230769234,23.357301053846154,23.948873876923077,{"y":24.5404467,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.85,17.06402748923077,17.27805497846154,17.49208246769231,17.70610995692308,17.92013744615385,18.134164935384618,18.348192424615384,18.562219913846153,18.776247403076923,18.990274892307692,19.20430238153846,19.41832987076923,{"y":19.63235736,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.496,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.285,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.315,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.5,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.875,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.15,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.53,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.1,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.26,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.32,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.2,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.1,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.85,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€29.45Average Price Target€24.54Lowest Price Target€19.63
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Cantor Fitzgerald Analyst forecast on DE:3O8
Cantor Fitzgerald
Cantor Fitzgerald
€19.63
Buy
21.94%
Upside
Reiterated
10/14/26
Analysts Are Bullish on These Healthcare Stocks: Omeros (OMER), Johnson & Johnson (JNJ)
Needham
―
Hold
―
Reiterated
08/13/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Sera Prognostics (NASDAQ: SERA) and Omeros (NASDAQ: OMER)
H.C. Wainwright Analyst forecast on DE:3O8
H.C. Wainwright
H.C. Wainwright
€29.45
Buy
82.91%
Upside
Reiterated
08/13/26
Omeros Maintained at Buy as Strong YARTEMLEA Launch and Reduced C5 Competition Support Unchanged $33 Price Target
WBB Securities Analyst forecast on DE:3O8
WBB Securities
WBB Securities
€40.16→€49.08
Buy
204.85%
Upside
Reiterated
01/08/26
Omeros (OMER) Receives a Buy from WBB Securities
D. Boral Capital Analyst forecast on DE:3O8
D. Boral Capital
D. Boral Capital
€32.13
Buy
99.54%
Upside
Reiterated
12/24/25
D. Boral Capital notes Omeros' YARTEMLEA FDA win, maintains Buy ratingD. Boral Capital notes Omeros' YARTEMLEA FDA win, maintains Buy rating
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Cantor Fitzgerald Analyst forecast on DE:3O8
Cantor Fitzgerald
Cantor Fitzgerald
€19.63
Buy
21.94%
Upside
Reiterated
10/14/26
Analysts Are Bullish on These Healthcare Stocks: Omeros (OMER), Johnson & Johnson (JNJ)
Needham
―
Hold
―
Reiterated
08/13/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Sera Prognostics (NASDAQ: SERA) and Omeros (NASDAQ: OMER)
H.C. Wainwright Analyst forecast on DE:3O8
H.C. Wainwright
H.C. Wainwright
€29.45
Buy
82.91%
Upside
Reiterated
08/13/26
Omeros Maintained at Buy as Strong YARTEMLEA Launch and Reduced C5 Competition Support Unchanged $33 Price Target
WBB Securities Analyst forecast on DE:3O8
WBB Securities
WBB Securities
€40.16→€49.08
Buy
204.85%
Upside
Reiterated
01/08/26
Omeros (OMER) Receives a Buy from WBB Securities
D. Boral Capital Analyst forecast on DE:3O8
D. Boral Capital
D. Boral Capital
€32.13
Buy
99.54%
Upside
Reiterated
12/24/25
D. Boral Capital notes Omeros' YARTEMLEA FDA win, maintains Buy ratingD. Boral Capital notes Omeros' YARTEMLEA FDA win, maintains Buy rating
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
REPLReplimune Group
OVIDOvid Therapeutics
IMUXImmunic
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Omeros

3 Months
Brandon FolkesH.C. Wainwright
Success Rate
12/20 ratings generated profit
60%
Average Return
+26.83%
Copying Brandon Folkes's trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +26.83% per trade.
1 Year
Stephen BrozakWBB Securities
Success Rate
9/11 ratings generated profit
82%
Average Return
+56.22%
Copying Stephen Brozak's trades and holding each position for 1 Year would result in 81.82% of your transactions generating a profit, with an average return of +56.22% per trade.
2 Years
Brandon FolkesH.C. Wainwright
Success Rate
15/20 ratings generated profit
75%
Average Return
+107.31%
Copying Brandon Folkes's trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +107.31% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

3O8 Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
4
4
5
3
2
Buy
0
0
0
1
2
Hold
3
3
3
2
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
7
8
6
5
In the current month, 3O8 has received 4 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 3O8 average Analyst price target in the past 3 months is 24.54.
Each month's total comprises the sum of three months' worth of ratings.

3O8 Financial Forecast

3O8 Earnings Forecast

Next quarter’s earnings estimate for 3O8 is €0.03 with a range of €0.02 to €0.04. The previous quarter’s EPS was €0.13. 3O8 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 3O8 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 3O8 is €0.03 with a range of €0.02 to €0.04. The previous quarter’s EPS was €0.13. 3O8 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 3O8 has Performed in-line its overall industry.

3O8 Sales Forecast

Next quarter’s sales forecast for 3O8 is €33.26M with a range of €27.57M to €36.23M. The previous quarter’s sales results were €25.46M. 3O8 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 3O8 has Performed in-line its overall industry.
Next quarter’s sales forecast for 3O8 is €33.26M with a range of €27.57M to €36.23M. The previous quarter’s sales results were €25.46M. 3O8 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 3O8 has Performed in-line its overall industry.

3O8 Stock Forecast FAQ

What is DE:3O8’s average 12-month price target, according to analysts?
Based on analyst ratings, Omeros Corp’s 12-month average price target is 24.54.
    What is DE:3O8’s upside potential, based on the analysts’ average price target?
    Omeros Corp has 52.43% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Omeros Corp a Buy, Sell or Hold?
          Omeros Corp has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Omeros Corp’s share price target?
            The average share price target for Omeros Corp is 24.54. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €29.45 ,and the lowest forecast is €19.63. The average share price target represents 52.43% Increase from the current price of €16.1.
              What do analysts say about Omeros Corp?
              Omeros Corp’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
                How can I buy shares of Omeros Corp?
                To buy shares of DE:3O8, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.